Monday, April 27, 2020 12:04:51 PM
You make some very good points here. Speaking strictly for myself, my current "disappointment" is not based on Avita's product(s), or its longer-term future. In fact, I believe they have a great future.
My disappointment surrounds the coming reverse split (assuming they get the votes and nothing else stops it). While they gave some good reasons for the redomiciliation, and I'm not opposed to it, reverse splits almost always cause loss of value for current shareholders (as we've seen the last few trading days). Often times that loss can become significant . How necessary is a reverse split - particularly during this challenging time? I'm just not sure I buy into this aspect of the change. I'm also very puzzled by the complete lack of any word on Japanese approval. This was supposed to have taken place by February (according to previous PR's). I realize that the CV pandemic likely has been the reason for delay, but have not received an answer to repeated questions I've asked the company about this topic.
Hopefully all of this will be moot a couple of years from now and Avita will be thriving.
Lastly - on a somewhat humorous note - I believe it's Pediatric "scalds" that they are in pivotal trials for, rather than Pediatric skulls. Don't believe RCEL is intended for bones.
JMHO
Recent RCEL News
- AVITA Medical to Announce First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/15/2024 09:05:00 PM
- AVITA Medical Updates Expected First Quarter 2024 Revenue • GlobeNewswire Inc. • 04/10/2024 09:11:25 PM
- AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement • GlobeNewswire Inc. • 02/29/2024 09:02:00 PM
- AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/29/2024 02:00:00 PM
- AVITA Medical to Host Investor Webinar Briefing • GlobeNewswire Inc. • 02/23/2024 02:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:02:06 PM
- AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance • GlobeNewswire Inc. • 02/22/2024 09:01:00 PM
- AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/01/2024 09:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:05:12 PM
- AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific • GlobeNewswire Inc. • 01/10/2024 09:01:00 PM
- AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update • GlobeNewswire Inc. • 01/10/2024 02:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:51:10 PM
- AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/04/2024 02:00:00 PM
- AVITA Medical to Host Investor Webinar Briefing • GlobeNewswire Inc. • 12/04/2023 02:00:00 PM
- AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference • GlobeNewswire Inc. • 11/21/2023 09:15:00 PM
- Keep An Eye Out: Pre-Market Movers And Analyst Recommendations • IH Market News • 11/21/2023 02:10:28 PM
- AVITA Medical Updates Full Year 2023 Guidance • GlobeNewswire Inc. • 11/20/2023 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:09:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:07:10 PM
- AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year • GlobeNewswire Inc. • 11/09/2023 09:01:00 PM
- AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe • GlobeNewswire Inc. • 11/09/2023 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:36:53 PM
- AVITA Medical to Announce Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 10/19/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 01:07:51 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM